Author Archives: wesley

Policy Analysis and Guidance: Sichuan’s Drug and Medical Device Advertising Review Announcement

Sichuan Provincial Drug Administration has released the advertising review information announcement for drugs and medical devices (Issue 12, 2025). This initiative aims to ensure the legality and accuracy of advertising content, Maintain market order, and protect consumer rights.

Key Policy Highlights

Review Criteria
- Legality: Advertisements must comply with national drug and medical device advertising laws and regulations.
- Accuracy: Ad content must accurately reflect product information, avoiding misleading or false claims.
Review Process
- Transparency: The review process is open and transparent, with detailed information on reviewed products and enterprises publicly available.
- Efficiency: Timely review and decision-making to ensure market agility and responsiveness.
Market Supervision
- Regulation: Enhanced supervision to ensure compliance with advertising standards.
- Penalties: Strict penalties for non-compliant advertisements to maintain market integrity.

Policy Orientation and Industry Implications
The advertising review policy reflects Sichuan’s strategic focus on:

Consumer Protection: Ensuring consumers have access to accurate and truthful product information.
Market Integrity: Promoting fair competition and preventing misleading advertising practices.
Regulatory Efficiency: Streamlining the review process to support industry development and innovation.

Conclusion
Sichuan’s approach to drug and medical device advertising review sets a benchmark for regional regulation, emphasizing legality, accuracy, and market integrity. Stakeholders in the pharmaceutical and medical device sectors should align with these guidelines to maintain compliance and consumer trust.-China Health Reform Pulse

Policy Source: http://yjj.sc.gov.cn/scyjj/c103179/2025/3/31/d2372efe246a44b5bf465e68ff31497d.shtml

Policy Analysis and Guidance: Sichuan Provincial Drug Administration’s Policy Update

Sichuan Provincial Drug Administration has released a policy update aimed at enhancing drug regulation and market management. This initiative reflects the province’s commitment to ensuring drug safety, quality, and accessibility for consumers.

Key Policy Highlights

Regulatory Enhancement
- Purpose: Strengthening oversight of pharmaceutical products to ensure compliance with national standards.
- Measures: Implementing stricter inspection and approval processes for drug manufacturers and distributors.
Market Management
- Focus: Addressing market order and ensuring fair competition among pharmaceutical enterprises.
- Actions: Conducting regular market checks and taking action against non-compliant entities.
Consumer Protection
- Safety: Prioritizing consumer safety through rigorous quality control measures.
- Accessibility: Ensuring the availability of essential medications through efficient market management.

Policy Orientation and Industry Implications
The policy update reflects Sichuan’s strategic focus on:

Quality Assurance: Emphasizing the importance of drug quality and safety.
Regulatory Efficiency: Enhancing the efficiency and effectiveness of regulatory measures.
Market Stability: Ensuring a stable and competitive pharmaceutical market for consumers.

Conclusion
Sichuan’s approach to drug administration policy sets a benchmark for regional regulation, emphasizing quality, safety, and market stability. Stakeholders in the pharmaceutical sector should align with these guidelines to maintain compliance and ensure patient access to essential medications.-China Health Reform Pulse

Policy Source: http://yjj.sc.gov.cn/scyjj/c103182/2025/3/31/85f25c8762c84d31a6f0467d504cd407.shtml

Policy Analysis and Guidance: Xinjiang’s Priority Registration for Medical Device Applications

Xinjiang’s Drug Evaluation and Inspection Center has released a notice on the priority registration application review results for medical devices (2025 No. 1). This initiative aims to expedite the registration process for specific medical devices, reflecting the region’s commitment to supporting innovation and addressing public health needs.

Key Policy Highlights

Priority Registration Criteria
- Basis: Applications are reviewed under the “Xinjiang Uygur Autonomous Region Second-Class Medical Device Special Registration Procedure” (Announcement No. 39, 2021).
- Purpose: To accelerate the registration of devices that meet specific priority criteria.
Publicize Details
- Period: The public announcement period is from March 24 to 28, 2025.
- Content: Lists the product “Electronic Gastroscopy” by Xinjiang Ruijiang Biotechnology Co., Ltd., which qualifies for priority registration due to meeting specific criteria.
Objection Process
- Contact: Stakeholders with objections are encouraged to contact the center within the announcement period.

Policy Orientation and Industry Implications
The priority registration policy reflects Xinjiang’s strategic focus on:

Innovation Support: Accelerating the market entry of innovative medical devices.
Public Health: Addressing urgent public health needs through faster access to critical devices.
Regulatory Efficiency: Streamlining the registration process to support industry development.

Conclusion
Xinjiang’s priority registration initiative for medical devices sets a precedent for regional regulatory support, emphasizing innovation and public health. Companies in the medical device sector should leverage this policy to expedite product development and market entry.-China Health Reform Pulse

Policy Source: http://mpa.xinjiang.gov.cn/xjyjj/ylqxggtg/202503/b44f72f43777439793f7df0b2bb3673d.shtml